F42I (p.Phe42Ile) variant of B2M (Beta-2-microglobulin)
F42I (p.Phe42Ile) in B2M (Beta-2-microglobulin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
F42I (p.Phe42Ile) variant details
- p.Phe42Ile
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available